Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Livingstone Health Holdings Yönetim

Yönetim kriter kontrolleri 2/4

Livingstone Health Holdings' CEO'su Wilson Tay, Jan2021 tarihinde atandı, in görev süresi 3.75 yıldır. şirketin hisselerinin 7.93% doğrudan sahiptir ve bu hisselerin değeri SGD 1.45M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.8 yıl ve 5 yıldır.

Anahtar bilgiler

Wilson Tay

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	3.8yrs
CEO sahipliği	7.9%
Yönetim ortalama görev süresi	3.8yrs
Yönetim Kurulu ortalama görev süresi	5yrs

Son yönetim güncellemeleri

Recent updates

CEO

Wilson Tay (45 yo)

3.8yrs

Görev süresi

Dr. Ching Yit Tay is also known as Wilson, M.B.B.S. (Singapore), M.Med Anaes (Singapore), F.A.M.S. (Anaes), F.I.P.P. (WIP, USA), C.I.P.S. (WIP, USA) serves as Chief Executive Officer at Livingstone Health...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Ching Yit Tay	Executive Director & CEO	3.8yrs	Veri yok	7.93% SGD 1.5m
Qingyuan Wong	Chief Financial Officer	less than a year	Veri yok	0.75% SGD 136.9k
Pang Yen Lim	Head of Aesthetics & Wellness and Medical Director	less than a year	Veri yok	3.19% SGD 585.3k
Meng Hui Chua	Head of Anaesthesiology & Pain Management	6yrs	Veri yok	3.96% SGD 725.5k
Yung Sern Ng	Chief Commercial Officer & Executive Director	4.8yrs	Veri yok	1.72% SGD 315.0k
Chua Hshan Cher	Deputy CEO & Head of Family Medicine	no data	Veri yok	0.66% SGD 120.4k
Jong Yuh Gn	Secretary	no data	Veri yok	Veri yok
Kai Lun Lee	Medical Director & Family Physician	no data	Veri yok	0.47% SGD 86.9k

3.8yrs

Ortalama Görev Süresi

45yo

Ortalama Yaş

Deneyimli Yönetim: PRH 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Ching Yit Tay	Executive Director & CEO	3.7yrs	Veri yok	7.93% SGD 1.5m
Yung Sern Ng	Chief Commercial Officer & Executive Director	less than a year	Veri yok	1.72% SGD 315.0k
Heng Fong	Lead Independent Non-Executive Director	6.3yrs	Veri yok	Veri yok
Wing Kwan Teh	Non Independent & Non Executive Chairman	6.3yrs	Veri yok	4.66% SGD 855.0k
Jun Xiong Lim	Independent Non-Executive Director	3.7yrs	Veri yok	Veri yok
Yu Meng Chan	Independent Non-Executive Director	6.3yrs	Veri yok	Veri yok

5.0yrs

Ortalama Görev Süresi

51.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: PRH 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5 yıldır).

Livingstone Health Holdings Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

High number of new directors

Livingstone Health Holdings Limited, Annual General Meeting, Jul 31, 2024

Insufficient new directors

Livingstone Health Holdings Limited, Annual General Meeting, Jul 27, 2023

Livingstone Health Holdings Limited Announces the Cessation of Mr. Leow Chin Yew as Group Financial Controller

Livingstone Health Holdings Limited Announces Cessation of Cindy Lau Sok Mui (Liu Shumei) as Head of Operations

Recent updates

High number of new directors

Livingstone Health Holdings Limited, Annual General Meeting, Jul 31, 2024

Full year 2024 earnings released: S$0.65 loss per share (vs S$0.002 profit in FY 2023)

New minor risk - Financial data availability

Livingstone Health Holdings Limited to Report Fiscal Year 2024 Results on May 30, 2024

Livingstone Health Holdings Limited has filed a Follow-on Equity Offering in the amount of SGD 1.574235 million.

New minor risk - Shareholder dilution

Livingstone Health Holdings Limited has completed a Follow-on Equity Offering in the amount of SGD 1.500039 million.

Livingstone Health Holdings Limited has filed a Follow-on Equity Offering in the amount of SGD 1.500039 million.

Livingstone Health Holdings Limited has filed a Follow-on Equity Offering in the amount of SGD 1.500039 million.

Insufficient new directors

New major risk - Market cap size

Livingstone Health Holdings Limited to Report First Half, 2024 Results on Nov 14, 2023

New major risk - Market cap size

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: S$0.002 (vs S$0.009 in FY 2022)

Livingstone Health Holdings Limited, Annual General Meeting, Jul 27, 2023

Full year 2023 earnings released: EPS: S$0.002 (vs S$0.01 in FY 2022)

Livingstone Health Holdings Limited Announces the Cessation of Mr. Leow Chin Yew as Group Financial Controller

First half 2023 earnings released: EPS: S$0.002 (vs S$0.006 in 1H 2022)

Livingstone Health Holdings Limited Announces Cessation of Cindy Lau Sok Mui (Liu Shumei) as Head of Operations

Livingstone Health Holdings Limited Proposes First and Final One-Tier Tax Exempt Dividend for the Financial Year Ended 31 March 2022, Payable on August 29, 2022

Livingstone Health Holdings Limited Proposes First and Final One-Tier Tax Exempt Dividend, Payable on 11 August 2022

Head of Orthopaedic Surgery recently bought S$4.8m worth of stock

Livingstone Health Holdings Limited Proposes Final Dividend

Livingstone Health Holdings Limited Appoints Chua Hshan Cher as Deputy Chief Executive Officer

Livingstone Health Launches One-Stop Health Screening Centre Ardennes Healthcare Pte Ltd

Livingstone Health Holdings Limited to Report Fiscal Year 2021 Results on May 30, 2021

Livingstone Health Holdings Limited Appoints Lim Jun Xiong Steven as Independent and Non-Executive Director

Livingstone Health Ltd. completed the acquisition of Citicode Ltd. (SGX:5FH) in a reverse merger transaction.

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş